IE
NPCE icon

Israel Englander’s Neuropace NPCE Stock Holding History

Israel Englander’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Sell
30,619
-10,002
-25% -$161K ﹤0.01% 4790
2026
Q1 		$534K Sell
40,621
-53,114
-57% -$797K ﹤0.01% 4734
2025
Q4 		$1.45M Buy
+93,735
New +$1.25M ﹤0.01% 4213
2025
Q2 		– Sell
-268,716
Closed -$3.3M – 6190
2025
Q1 		$3.3M Sell
268,716
-374,495
-58% -$4.69M ﹤0.01% 3288
2024
Q4 		$7.2M Sell
643,211
-96,782
-13% -$842K ﹤0.01% 2478
2024
Q3 		$5.16M Buy
739,993
+53,956
+8% +$395K ﹤0.01% 2813
2024
Q2 		$5.19M Buy
686,037
+80,324
+13% +$810K ﹤0.01% 2690
2024
Q1 		$8M Buy
605,713
+433,310
+251% +$6.18M ﹤0.01% 2406
2023
Q4 		$1.78M Sell
172,403
-11,766
-6% -$93.8K ﹤0.01% 3706
2023
Q3 		$1.79M Sell
184,169
-444,764
-71% -$2.6M ﹤0.01% 3661
2023
Q2 		$2.82M Sell
628,933
-102,677
-14% -$465K ﹤0.01% 3184
2023
Q1 		$3.4M Buy
731,610
+39,711
+6% +$152K ﹤0.01% 2951
2022
Q4 		$1.03M Buy
691,899
+106,532
+18% +$237K ﹤0.01% 4133
2022
Q3 		$2.19M Buy
585,367
+78,462
+15% +$378K ﹤0.01% 3655
2022
Q2 		$2.51M Buy
506,905
+83,877
+20% +$554K ﹤0.01% 3473
2022
Q1 		$3.47M Buy
423,028
+304,391
+257% +$2.63M ﹤0.01% 3343
2021
Q4 		$1.2M Sell
118,637
-86,809
-42% -$1.13M ﹤0.01% 4244
2021
Q3 		$3.26M Sell
205,446
-48,792
-19% -$1.02M ﹤0.01% 3360
2021
Q2 		$6.05M Buy
+254,238
New +$5.9M ﹤0.01% 2504

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Israel Englander's NPCE Position: Q2 2026 in Review

Israel Englander reduced its Neuropace (NPCE) stake by 25% in Q2 2026, selling an estimated $161K and leaving 30,619 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #4790.

Israel Englander first reported a position in NPCE in Q2 2021 and has held it in 19 quarters since. The position peaked at $8M in Q1 2024. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Israel Englander held 30,619 shares of Neuropace worth $487K as of Q2 2026.
  • Israel Englander sold 10,002 Neuropace shares in Q2 2026, an estimated $161K.
  • Neuropace made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4790 holding.
  • Israel Englander first reported a position in Neuropace in Q2 2021 and has held it in 19 quarters since.
  • Israel Englander's Neuropace position peaked at $8M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.